ISSN: 2575-9981
Authors: Austine EI, Brian OO*, Maureen UA, Amarachi SE, Ifeoma BU, Sunday ON, Nkeiruka GO, Joseph OM, Chigozie UV and Eze DU
The “test and treat” recommendation of WHO for all people newly diagnosed with HIV based on sufficient evidence that early ART initiation reduces morbidity and mortality among AIDS patients promoted expanded strategies for universal access. This call for expanded strategies of universal access to antiretroviral resulted in an upsurge of patients in public health facilities causing long waiting times and dissatisfaction which are poorly staffed with inadequate facilities. The overcrowding of public health facilities resulted in the devolvement of patients to community pharmacies. This study evaluates the roles of community pharmacies as outreach to people living with AIDS through access to potent antiretroviral initiated to reduce morbidity and mortality. Respondents were mostly males with a modal age of 50-59 with positive attitudes and perceptions with high knowledge. Responsive provision of screening tests and adherence modification through telephones and SMS enhanced by behavioural adherence training were key features of care. The study reveals a clear reduction of the burden of treatment visits, and costs and sustains treatment outcomes tailored to the needs of various groups of people living with HIV/AIDS in the Differentiated care service delivery of community pharmacies.
Keywords: Differentiated Care; Community Pharmacists Based-Care; Innovative Services
